Skip to content
Trial Eligibility
Menu

Connect for Cancer Prevention Study (Connect)

NCT04609072

This study is recruiting at 9 US sites in 9 states, according to its ClinicalTrials.gov record last updated .

Summary

Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of people affected by cancer. By taking part in Connect, participants can help researchers learn how the way we live, our genetics, and our health history may affect cancer risk. Objective: To study and better understand the causes of cancer and to find new ways to prevent it.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Cancer
  • General Research Use

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
30 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Cancer Institute (NCI)
Last updated on ClinicalTrials.gov
October 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Kaiser Permanente Colorado · Denver, CO

Georgia · 1

  • Kaiser Permanente Georgia · Atlanta, GA

Hawaii · 1

  • Kaiser Permanente Hawaii · Honolulu, HI

Michigan · 1

  • Henry Ford Health Systems · Detroit, MI

Minnesota · 1

  • HealthPartners · Minneapolis, MN

Oregon · 1

  • Kaiser Permanente Northwest · Portland, OR

South Dakota · 1

  • Sanford Health · Sioux Falls, SD

Texas · 1

  • Baylor Scott and White Health · Dallas, TX

Wisconsin · 1

  • Marshfield Clinic Health System · Marshfield, WI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.